Tsirakis George, Kanellou Peggy, Kaparou Maria, Passam Andrew, Zampoulaki Amalia, Stylianou Kostas, Alexandrakis Michael G
Department of Haematology, University Hospital of Heraklion, 71110 Heraklion Crete, Greece.
ISRN Hematol. 2011;2011:404057. doi: 10.5402/2011/404057. Epub 2011 May 19.
Introduction. Coexistence of myeloproliferative neoplasms with lymphoproliferative syndromes has been described in the past, whereas plasma cell dyscrasias seem to be the most common cases. Case Presentation. We present a case of a 59-year-old Caucasian female of Greek origin who presented with thrombocytosis. Clinical and laboratory investigation disclosed the presence of a smoldering myeloma with coexisting histological and molecular characteristics of primary myelofibrosis. The patient had the acquired point mutation V617F in the JAK2 gene but not the bcr-abl rearrangement and was treated for myelofibrosis with subsequent improvement of all haematological parameters without evidence of myelomatic evolution. Conclusion. We present the first case in the literature of a smoldering myeloma coexisting with primary myelofibrosis. The underlying pathogenetic mechanism could be either related to the presence of a pluripotent neoplastic stem cell capable to differentiate into both lymphoid and myeloid cells or be related to two separate nosologic entities.
引言。过去曾描述过骨髓增殖性肿瘤与淋巴增殖性综合征并存的情况,而浆细胞异常增生似乎是最常见的病例。病例报告。我们报告一例59岁的希腊裔白种女性,表现为血小板增多症。临床和实验室检查发现存在冒烟型骨髓瘤,并伴有原发性骨髓纤维化的组织学和分子特征。该患者JAK2基因存在获得性点突变V617F,但无bcr-abl重排,接受了骨髓纤维化治疗,随后所有血液学参数均有改善,且无骨髓瘤进展迹象。结论。我们报告了文献中首例冒烟型骨髓瘤与原发性骨髓纤维化并存的病例。潜在的发病机制可能与能够分化为淋巴样和髓样细胞的多能肿瘤干细胞的存在有关,也可能与两个独立的疾病实体有关。